Healthcare -
Biotechnology - NASDAQ - US
$ 5.655
-1.82 %
$ 347 M
Market Cap
-3.18
P/E
GLUE - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities GLUE - Monte Rosa Therapeutics, Inc.
27.5 M
LAST VALUE
-73.02%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR